When choosing a peptide, consider the target: central gonadotropin drive (gonadorelin, kisspeptin) versus growth-hormone mediated improvements (tesamorelin, CJC-1295)
Several large-scale cardiovascular outcome trials (including LEADER, SUSTAIN-6, and REWIND) have shown that certain GLP-1 receptor agonists liraglutide, semaglutide, and dulaglutide reduce the risk of major adverse cardiovascular events such as heart attack, stroke, and cardiovascular death in people with established cardiovascular disease or multiple cardiovascular risk factors
Independent Pharmacies: The growth of mail-order counteracts independent pharmacies business for chronic meds
Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, activities of regulators and future regulations, the ability to obtain, maintain and enforce patent protection, whether patent applications will issue or claims will be allowed, clinical and regulatory development timelines, potential indications, safety and efficacy, and market opportunity
Twice-weekly sessions during the first month tend to accelerate early progress